(firstQuint)Treatment of West Nile Virus With MGAWN1.

 The objective of this study is to evaluate the safety, efficacy, and pharmacokinetics of MGAWN1 in subjects with West Nile Fever or a syndrome compatible with West Nile Neuroinvasive Disease (WNND) [encephalitis, meningitis, or acute flaccid paralysis].

 Subjects can be enrolled based on a syndrome compatible with WNND, and do not need documented West Nile virus infection.

.

 Treatment of West Nile Virus With MGAWN1@highlight

This study will test a drug called MGAWN1 for the treatment of West Nile infections.

